Structure of the intestinal barrier
Abstract
Keywords
Full Text:
PDF (Język Polski)References
Caricilli AM, Castoldi A, Câmara NO. Intestinal barrier: A gentlemen’s agreement between microbiota and immunity. World J Gastrointest Pathophysiol 2014;5(1):18 32. doi: 10.4291/wjgp.v5.i1.18.
Rescigno M. Dendritic cells in oral tolerance in the gut. Cell Microbiol 2011;13(9):1303-8. doi: 10.1111/j.1462 5822.2011.01626.x.
Konig MF, Abusleme L, Reinholdt J, Palmer RJ, Teles RP, Sampson K, et al. Aggregatibacter actinomycetemcomitans-induced hypercitrullination links periodontal infection to autoimmunity in rheumatoid arthritis. Sci Transl Med 2016;8:369. doi: 10.1126/scitranslmed.aaj1921.
Kawashima H. Roles of the gel-forming MUC2 mucin and its O-glycosylation in the protection against colitis and colorectal cancer. Biol Pharm Bull 2012;35(10):1637-41.
Nowak A, Libudzisz Z. Ability of probiotic Lactobacillus casei DN 114001 to bind or/an metabolise hetereocyclic aromatic amines in vitro. Eur J Nutr 2009;48(7):419-27. doi: 10.1007/s00394-009-0030-1.
Cammarota G, Ianiro G, Bibbo S, Gasbarrini A. Gut microbiota modulation: probiotics, antibiotics or fecal microbiota transplantation? Intern Emerg Med 2014;9(4):365-73. doi: 10.1007/s11739-014-1069-4.
Krakowiak O, Nowak R. Mikroflora przewodu pokarmowego człowieka – znaczenie, rozwój, modyfikacje. Post Fitoter 2015;3:193-200.
Tappenden KA, Deutsch AS. The physiological relevance of the intestinal microbiota – contributions to human health. J Am Coll Nutr 2007;26(6):679-83.
Purchiaroni F, Tortora A, Gabrielli M, Bertucci F, Gigante G, Ianiro G, et al. The role of intestinal microbiota and the immune system. Eur Rev Med Pharmacol Sci 2013;17(3):323-33.
Wu M, Wu Y, Deng B, Li J, Cao H, Qu Y, et al. Isoliquiritigenin decreases the incidence of colitis associated colorectal cancer by modulating the intestinal micro biota. Oncotarget 2016;7(51):85218-331. doi: 10.18632/oncotarget.13347.
Van Der Flier L, Clevers H. Stem cells, self-renewal, and differentiation in the intestinal epithelium. Annu Rev Physiol 2009;71:241-60. doi: 10.1146/annurev.physiol.010908.163145.
Pott J, Hornef M. Innate immune signalling at the intestinal epithelium in homeostasis and disease. EMBO Rep 2012;13(8):684-98. doi: 10.1038/embor.2012.96.
Lee SH. Intestinal permeability regulation by tight junction: implication on inflammatory bowel diseases. Intest Res 2015;13(1):11-8. doi: 10.5217/ir.2015.13.1.11.
Turner JR, Rill BK, Carlson SL, Carnes D, Kerner R, Mrsny RJ, et al. Physio¬logical regulation of epithelial tight junctions is associated with myosin light-chain phosphorylation. Am J Physiol 1997;273:1378-85.
Umeda K, Matsui T, Nakayama M, Furuse K, Sasaki H, Furuse M, et al. Establishment and characterization of cultured epithelial cells lacking expression of ZO-1. J Biol Chem 2004;279(43):44785-94. doi: 10.1074/jbc.M406563200.
Drago S, El Asmar R, Di Pierro M, Grazia Clemente M, Tripathi A, Sapone A, et al. Gliadin, zonulin and gut permeability: Effects on celiac and non-celiac intestinal mucosa an intestinal cell lines. Scand J Gastroenterol 2006;41(4):408-19. doi: 10.1080/00365520500235334.
Zeissig S, Bürgel N, Günzel D, Richter J, Mankertz J, Wahnschaffe U, et al. Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn’s disease. Gut 2007;56(1):61-72. DOI: 10.1136/gut.2006.094375.
Sander GR, Cummins AG, Henshall T, Powell BC. Rapid disruption of intestinal barrier function by gliadin involves altered expression of apical junctional proteins. FEBS Lett 2005;579(21):4851-5. doi: 10.1016/j.febslet.2005.07.066.
Al-Sadi R, Khatib K, Guo S, Ye D, Youssef M, Ma T. Occludin regulates macromolecule flux across the intestinal epithelial tight junction barrier. Am J Physiol Gastrointest Liver Physiol 2011;300(6):1054-64. doi: 10.1152/ajpgi.00055.2011.
Rao R. Occludin phosphorylation in regulation of epithelial tight junctions. Ann N Y Acad Sci 2009;1165:62-8. doi: 10.1111/j.1749-6632.2009.04054.x.
Martínez C, Lobo B, Pigrau M, Ramos L, González Castro AM, Alonso C, et al. Diarrhoea-predominant irritable bowel syndrome: an organic disorder with structural abnormalities in the jejunal epithelial barrier. Gut 2013;62(8):1160-8. doi: 10.1136/gutjnl-2012-302093.
Salvo-Romero E, Alonso-Cotoner C, Pardo-Camacho C, Casado-Bedmar M, Vicario M. The intestinal barrier function and its involvement in digestive disease. Rev Esp Enferm Dig 2015;107(11):686-96. doi: 10.17235/reed.2015.3846/2015.
Laukoetter MG, Nava P, Lee WY, Severson EA, Capaldo CT, Babbin BA, et al. JAM-A regulates permeability and inflammation in the intestine in vivo. J Exp Med 2007;204(13):3067-76. doi: 10.1084/jem.20071416.
Kojima T, Murata M, Go M, Spray DC, Sawada N. Connexins induce and maintain tight junctions in epithelial cells. J Membr Biol 2007;217(1-3):13-9. doi: 10.1007/s00232-007-9021-4.
Gill N, Wlodarska M, Finlay B. Roadblocks in the gut: barriers to enteric infection. Cell Microbiol 2011;13(5):660 9. doi: 10.1111/j.1462-5822.2011.01578.x.
Jónsdóttir I. Maturation of mucosal immune responses and influence of maternal antibodies. J Comp Pathol 2007;137:20-6. doi: 10.1016/j.jcpa.2007.04.007.
Woodland DL, Randall TD. Anatomical features of anti-viral immunity in the respiratory tract. Semin Immunol 2004;16(3):163-70. doi: 10.1016/j.smim.2004.02.003.
Fasano A. Leaky gut and autoimmune diseases. Clin Rev Allergy Immunol 2012;42(1):71-8. doi: 10.1007/s12016 011-8291-x.
Prasad S, Mingrino R, Kaukinen K, Hayes KL, Powell RM, MacDonald TT, et al. Inflammatory processes have differential effects on claudins 2, 3 and 4 in colonic epithelial cells. Lab Invest 2005;85(9):1139-62. doi: 10.1038/labinvest.3700316.
Nouri M, Bredberg A, Weström B, Lavasani S. Intestinal barrier dysfunction develops at the onset of experimental autoimmune encephalomyelitis, and can be induced by adoptive transfer of auto-reactive T cells. PLoS One 2014;9(9):106335. doi: 10.1371/journal.pone.0106335.
Zhang D, Zhang L, Yue F, Zheng Y, Russell R. Serum zonulin is elevated in women with polycystic ovary syndrome and correlates with insulin resistance and severity of anovulation. Eur J Endocrinol 2015;172(1):29-36. doi: 10.1530/EJE-14-0589.
DOI: https://doi.org/10.21164/pomjlifesci.278
Copyright (c) 2017 Dagmara Węgrzyn, Karolina Adamek, Beata Łoniewska
License URL: https://creativecommons.org/licenses/by-nc-nd/3.0/pl/